DMSO pp 48-53 | Cite as

The Tilt Formula for CNS Lesions: Effects of Dimethyl Sulfoxide

  • J. C. De la Torre
  • M. T. Richard
  • L. P. Ivan


There are presently no criteria to grade CNS lesions for the purpose of assessing the value of an experimental or clinical therapy. We have devised a simple formula to score CNS injuries that allows evaluation of the strength of a given treatment. The formula is based on 4 descriptive parameters which characterize the lesion. These factors are: type of lesion, intensity, location and time of duration (TILT). When each parameter in TILT is graded, a collective score can be expressed which results in an index of therapeutic efficacy with respect to a given treatment as applied to the CNS lesion (Traumindex). For the purpose of analysis, we have chosen to evaluate the therapeutic index of dimethyl sulfoxide (DMSO) because a number of studies have reported using this drug for a wide range of CNS lesions in both experimental and clinical subjects (s. References).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albin MS, Bunegin L, Helsel P (1983) Dimethyl sulfoxide and other therapies in experimental pressure-induced cerebral focal ischemia. In: J C de la Torre (ed) Biological actions and medical applications of dimethyl sulfoxide. Ann NY Acad Sci 411: 261–268Google Scholar
  2. Brown F, Johns LM, Mullan S (1980) Dimethyl sulfoxide in experimental brain injury, with comparison to mannitol. J Neurosurg 53: 58–62PubMedCrossRefGoogle Scholar
  3. Camp PE, James HE, Werner R (1981) Acute dimethylsulfoxide therapy in experimental brain edema, part 1. J Neurosurg 9: 28–33CrossRefGoogle Scholar
  4. de la Torre JC, Surgeon JW (1976) Dexamethasone and DMSO in experimental transorbital cerebral infarction. Stroke 7(6): 577–583PubMedCrossRefGoogle Scholar
  5. de la Torre JC, Rowed DW, Kawanaga HM, Mullan S (1973) Dimethyl sulfoxide in the treatment of experimental brain compression. J Neurosurg 38: 345–354PubMedCrossRefGoogle Scholar
  6. de la Torre JC, Kawanaga HM, Rowed DW, Johnson CM et al. (1975) Dimethyl sulfoxide in central nervous system trauma. Ann NY Sci 243: 362–389CrossRefGoogle Scholar
  7. Del Bigio M, James H, Camp PE, Werner R, Marshall LF, Jung H (1982) Acute dimethyl sulfoxide therapy in brain edema. J Neurosurg 10: 86–89CrossRefGoogle Scholar
  8. Dujovny M, Rozario R, Kossovsky N, Diaz FG, Segal R (1983) Antiplatelet effect of dimethyl sulfoxide, barbiturates, and methyl prednisolone. In: JC de la Torre (ed) Biological actions and medical applications of dimethyl sulfoxide. Ann NY Acad Sci 411: 234–244Google Scholar
  9. Gumerlock MK, Neuwelt EA (1984) DMSO treatment for patients with intracranial pressure. Neurosurgery 14: 662–663Google Scholar
  10. James HE, Camp PE, Hakbaugh RD, Marshall LF, Werner R (1982) Comparison of the effects of DMSO and pentobarbitone on experimental brain oedema. Acta Neurochir (Wien) 60: 245–255CrossRefGoogle Scholar
  11. Laha RK, Dujovny M, Barrionuevo PJ, De Castro SC, Hellstrom HR, Maroon, JC (1978) Protective effects of methylprednisolone and dimethyl sulfoxide in experimental middle cerebral artery embolectomy. J Neurosurg 49: 508–516PubMedCrossRefGoogle Scholar
  12. Lim R, Mullan S (1975) Enhancement of resistance of glial cells by dimethyl sulfoxide against sonic disruption. Ann NY Acad Sci 243: 358–361PubMedCrossRefGoogle Scholar
  13. Little J, Cook A, Lesser R (1981) Treatment of acute focal cerebral ischemia with dimethyl sulfoxide. J Neurosurg 9: 34–39CrossRefGoogle Scholar
  14. Marshall LF, Camp PE, Bowers SA (1984) Dimethyl sulfoxide for the treatment of intracranial hypertension: A preliminary trial. J. Neurosurg 14(6): 659–663CrossRefGoogle Scholar
  15. McCallum JE (1984) Improvement in somatosensory evoked response amplitude and neurologic function following DMSO in a cat model of chronic spinal cord compression. In: Torre JC de la (ed) Biological actions and medical applications of dimethyl sulfoxide. Ann NY Acad Sci 411: 357–359Google Scholar
  16. McGraw CP (1977) The effect of dimethyl sulfoxide (DMSO) on cerebral infarction in the mongolian gerbil. Acta Neurol Scand 56: 160–161CrossRefGoogle Scholar
  17. Mullan S, Jafar J, Hanlon K, Brown F (1980) Dimethyl sulfoxide in the management of postoperative hemiplegia. In: Wilkins RH (ed) Cerebral arterial spasm. Williams & Wilkins, Baltimore, 646–653Google Scholar
  18. Munoz LG, Rozario RA, Dujovny M, Stroth D (1980) Anti platelet properties of DMSO and barbiturates demonstrated in microvessels with scanning electron microscopy. Am Assoc Neurol Surg (Sc Abstr) April 20-24Google Scholar
  19. Pace DG, Kovacs J, Klevans L (1982) Dimethyl sulfoxide inhibits platelet aggregation in partially obstructed canine coronary vessels. Fed Proc 41: 1530Google Scholar
  20. Rosenblum WI, El-Sabban F (1982) Dimethyl sulfoxide (DMSO) and glycerol, hydroxyl radical scavengers, impair platelet aggregation within and eliminate the accompanying vasodilation of injured mouse pia arterioles. Stroke 13: 35–39PubMedCrossRefGoogle Scholar
  21. Tsuruda J, James HE, Camp PE, Werner R (1982) Acute dimethyl sulfoxide therapy in experimental brain edema, part 2. J Neurosurg 10: 355–359CrossRefGoogle Scholar
  22. Tung H, James HE, Laurin R, Marshall LF (1983) Modification of the effect of dimethyl sulfoxide on intracranial pressure, brain water, and electrolyte content by indomethacin. Acta Neuro chir (Wien) 68: 101–110CrossRefGoogle Scholar
  23. Waller FT, Tanabe CT, Paxton MD (1983) Treatment of elevated intracranial pressure with dimethyl sulfoxide. Ann NY Acad Sci 411: 286–292PubMedCrossRefGoogle Scholar
  24. Willmore LJ, Rubin JJ (1984) The effect of tocopherol and dimethyl sulfoxide on focal edema and lipid peroxidation induced by isocortical injection of ferrous chloride. Brain Res 296: 389–392PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • J. C. De la Torre
  • M. T. Richard
  • L. P. Ivan

There are no affiliations available

Personalised recommendations